Alprolix IV 500, manufactured by Sanofi, contains eftrenonacog alpha (genetically recombination), a recombinant coagulation factor IX concentrate used to prevent and control bleeding in individuals with hemophilia B. It is available as 500 IU x 1 bottle with dissolving liquid (YJ code: 6343441D1028).
Alprolix IV 500
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →